Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Diabetes Mellitus: HELP
Matthias G. von Herrath
Based on 53 articles published since 2008
||||
Expertise Level
The expertise of Matthias G. von Herrath ranks in the
  • Top 0.022%
  • ... of 277,289 published authors worldwide on Diabetes Mellitus
  • ... from 2008 through 2018
  • ... based on contributions to 53 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases von Herrath, M   ·   von Herrath, Matthias   ·   von Herrath, Matthias G   ·   von Herrath, M G   ·   Von Herrath, Matthias G   ·   Von Herrath, Matthias
Work Locations
Details
Most likely:    La Jolla Institute for Allergy and Immunology      
2018
  • Department of Medicine, University of California, San Diego, San Diego, CA, USA. · Clinical and Translational Research Institute, University of California, San Diego, 9452 Medical Center Drive, L1W-515, La Jolla, CA, 920137, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, USA. · Novo Nordisk Diabetes Research and Development Center, 530 Fairview Ave N # 5000, Seattle, WA, USA. · Pubmed 29188386
2017
  • West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, Hohensandweg 37, 40591 Düsseldorf, Germany; Faculty of Medicine, University of Düsseldorf, 40225 Düsseldorf, Germany. Electronic address: · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92014, USA; Novo Nordisk Diabetes Research and Development Center, Seattle, WA 98191, USA. Electronic address: · Pubmed 27839907
  • Global Research Project Management, Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes Research Center, Novo Nordisk, Seattle, WA, USA; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92014, USA. Electronic address: · Pubmed 28978425
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Diabetes Research & Development Center, Seattle, Washington, USA. Electronic address: · Pubmed 28325643
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Division of Paediatric and Adolescent Medicine, Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Novo Nordisk Diabetes Research & Development Center, Seattle, WA. · Pubmed 28137793
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Institute of Diabetes Research, Helmholtz Diabetes Center, Helmholtz Zentrum München, Neuherberg, Germany. · Department of Pathology, University of Florida, Gainesville, FL. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Novo Nordisk Diabetes Research & Development Center, Seattle, WA. · Pubmed 28830918
  • Department of Pathology, Immunology, and Laboratory Medicine, 1395 Center Drive, College of Medicine, University of Florida, Gainesville, 32610, FL, USA. · Department of Pathology, Immunology, and Laboratory Medicine, 1395 Center Drive, College of Medicine, University of Florida, Gainesville, 32610, FL, USA. · Larry L. Hillblom Islet Research Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Cell Biology, University of Groningen, Groningen, the Netherlands. · Department of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Department of Virology, University of Tampere and Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland. · St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia. · University of Exeter Medical School, Exeter, UK. · Vanderbilt University Medical Center, Nashville, TN, USA. · Miller School of Medicine, University of Miami, Miami, FL, USA. · Department of Pathology, Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium. · Pubmed 28070616
2016
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. · Department of Clinical Immunology, University Hospital, Uppsala, Sweden. · Departments of Pathology and Pediatrics, University of Florida, Gainesville, FL, USA. · Pubmed 25989477
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA; Novo Nordisk Diabetes Research & Development Center, Seattle, WA, USA. Electronic address: · Pubmed 27491567
  • Institute of Immunity and Transplantation, University College London Division of Infection and Immunity, Royal Free Campus, London, UK. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA and Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. · Pubmed 26102289
  • Islet Biology Exeter (IBEx), Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, RILD Building (Level 4), Barrack Road, Exeter, EX2 5DW, UK. · La Jolla Institute for Allergy and Immunology, San Diego, CA, USA. · Department of Medicine, University of Tennessee, Memphis, TN, USA. · Department of Pathology, University of Florida, Gainesville, FL, USA. · Department of Information Sciences, City of Hope, Duarte, CA, USA. · Islet Biology Exeter (IBEx), Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, RILD Building (Level 4), Barrack Road, Exeter, EX2 5DW, UK. · Paediatric Department, Oslo University Hospital, Oslo, Norway. · Faculty of Medicine, University of Oslo, Oslo, Norway. · Diabetes Research Institute, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Miami Miller School of Medicine, Miami, FL, USA. · Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA. · Islet Biology Exeter (IBEx), Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, RILD Building (Level 4), Barrack Road, Exeter, EX2 5DW, UK. · Pubmed 27506584
  • Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA. Electronic address: · Pubmed 26821303
  • Departments of Surgery and Immunology, University of Colorado Denver, Aurora, CO · La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Departments of Surgery and Immunology, University of Colorado Denver, Aurora, CO. · Department of Pathology, University of Florida, Gainesville, FL. · Yale University School of Medicine, New Haven, CT. · Immune Tolerance Network, University of California, San Francisco, San Francisco, CA. · Immune Tolerance Network, Bethesda, MD. · JDRF, New York, NY. · Benaroya Research Institute, Seattle, WA. · Pubmed 26718498
2015
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California (TRC, JSS, NA, JZG, FA, SS, MGVH) · Department of Immunohematology & Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands (JSS) · Novo Nordisk Diabetes Research & Development Center, Seattle, Washington (MGVH) · Pubmed 26216138
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Novo Nordisk Diabetes Research and Development Center, Seattle, WA · Pubmed 25908875
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk, Inc., Seattle, WA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Type 1 Diabetes R&D Center, Novo Nordisk, Inc., Seattle, WA, USA. Electronic address: · Pubmed 25772283
  • Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, CA · Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, CA. · Department of Medicine, Columbia Center for Translational Immunology and Naomi Berrie Diabetes Center, Columbia University Medical Center, New York, NY. · Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Pubmed 25187368
2014
  • Department of Pediatrics, Herlev University Hospital, 2730 Herlev, Denmark;Glostrup Research Institute, Glostrup University Hospital, 2600 Glostrup, Denmark. · Department of Pediatrics, Herlev University Hospital, 2730 Herlev, Denmark; · Laboratory of Experimental Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium; · Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet, 2100 Copenhagen, Denmark; · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; · Global Development, Novo Nordisk A/S, 2860 Søborg, Denmark; · Department of Internal Medicine, University of Ulm, 89081 Ulm, Germany; · Department of Internal Medicine, University of Ulm, 89081 Ulm, Germany;Lee Kong Chian School of Medicine, Imperial College London and Nanyang Technological University, Singapore 637553; · Centre for Diabetes Research, Western Australian Institute for Medical Research, University of Western Australia, Perth, WA 6000, Australia; · Genetics Institute, University of Florida, Gainesville, FL 32610; · Hagedorn Research Institute, Novo Nordisk, 2820 Gentofte, Denmark; · Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; and. · Institute of Molecular Medicine and Cell Research and Centre for Biological Signalling Studies, Albert Ludwigs University, 79085 Freiburg, Germany. · Department of Pediatrics, Herlev University Hospital, 2730 Herlev, Denmark;Glostrup Research Institute, Glostrup University Hospital, 2600 Glostrup, Denmark,Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; and · Pubmed 24982147
  • Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA. · Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA. · Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA; Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA. · Pubmed 25393309
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, La Jolla, CA · Pubmed 25342729
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Department of Rheumatology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · Freelance consultant, San Diego, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Novo Nordisk Diabetes Research & Development Center, Seattle, WA · Pubmed 24947367
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Pubmed 24858581
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. Electronic address: · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · The School of Molecular Bioscience, University of Sydney, NSW 2006, Australia. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. Electronic address: · Pubmed 24582317
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Pubmed 24520125
  • La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; University of California San Diego, San Diego, CA, USA. · University of California San Diego, San Diego, CA, USA. · Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA. · Ayasdi, Inc., Palo Alto, CA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA. Electronic address: · Pubmed 24387802
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; University of California San Diego, San Diego, CA, USA. · University of California San Diego, San Diego, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. Electronic address: · Pubmed 25173803
2013
  • Center for Type 1 Diabetes Research, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Pubmed 23574316
  • Department for Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands. · Bayhill Therapeutics, Palo Alto, CA 94304, USA. · Foothill College, Los Altos, CA 94022, USA. · Barbara Davis Center for Childhood Diabetes, Aurora, CO 80045-6511, USA. · Division of Molecular Medicine, Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria 3052, Australia. · Pacific Northwest Diabetes Research Institute and University of Washington, Seattle, WA 98122, USA. · Diabetes Center for Research, University of North Carolina, Chapel Hill, NC 27599, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. · Departments of Medicine and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA. · Tolerion Inc., 321 Dedalera Drive, Portola Valley, CA 94028, USA. · Pubmed 23803704
2016
  • Type 1 Diabetes Center at the La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Pubmed 26300527
2014
  • La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA. · Pubmed 25073445
2013
  • Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Pubmed 23194064
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America. · Pubmed 24223938
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Pubmed 23770292
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA. · Pubmed 23434930
  • La Jolla Institute for Allergy and Immunology, Diabetes Center, La Jolla, CA, USA. · Pubmed 23405091
  • Type 1 Diabetes Center of San Diego, La Jolla Institute for Allergy and Immunology, La Jolla, 9420 Athena Circle, San Diego, CA 92037, USA. · Pubmed 22944096
  • La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Pubmed 24211845
2012
  • Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. · Pubmed 23051179
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. · Pubmed 22579473
Probable:    Novo Nordisk Seattle      
2018
  • Department of Medicine, University of California, San Diego, San Diego, CA, USA. · Clinical and Translational Research Institute, University of California, San Diego, 9452 Medical Center Drive, L1W-515, La Jolla, CA, 920137, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, USA. · Novo Nordisk Diabetes Research and Development Center, 530 Fairview Ave N # 5000, Seattle, WA, USA. · Pubmed 29188386
2017
  • West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, Hohensandweg 37, 40591 Düsseldorf, Germany; Faculty of Medicine, University of Düsseldorf, 40225 Düsseldorf, Germany. Electronic address: · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92014, USA; Novo Nordisk Diabetes Research and Development Center, Seattle, WA 98191, USA. Electronic address: · Pubmed 27839907
  • Global Research Project Management, Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes Research Center, Novo Nordisk, Seattle, WA, USA; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92014, USA. Electronic address: · Pubmed 28978425
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA; Pacific Northwest Diabetes Research Institute, Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Department of Histology and Imaging, Novo Nordisk A/S, Måløv, Denmark. · Department of Immunopharmacology, Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. Electronic address: · Pubmed 28711285
  • Molecular Development of the Immune System Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID) and Clinical Genomics Program, NIAID, National Institutes of Health, Building 10, Room 11D14, 10 Center Drive, Bethesda, MD, 20814, USA. · Novo Nordisk Type 1 Diabetes Center, Novo Nordisk Research Center, Seattle, WA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Wellstat Diagnostics, Gaithersburg, MD, USA. · Molecular Development of the Immune System Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID) and Clinical Genomics Program, NIAID, National Institutes of Health, Building 10, Room 11D14, 10 Center Drive, Bethesda, MD, 20814, USA. · Pubmed 28455654
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Diabetes Research & Development Center, Seattle, Washington, USA. Electronic address: · Pubmed 28325643
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Division of Paediatric and Adolescent Medicine, Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Novo Nordisk Diabetes Research & Development Center, Seattle, WA. · Pubmed 28137793
  • Histology and Imaging Department, Global Research, Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes Research Center, Global Research, Novo Nordisk Inc., Seattle, Washington. · Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Visiopharm, Hørsholm, Denmark. · Metabolic Disease Research, Global Research, Novo Nordisk A/S, Måløv, Denmark. · Pubmed 28094469
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Institute of Diabetes Research, Helmholtz Diabetes Center, Helmholtz Zentrum München, Neuherberg, Germany. · Department of Pathology, University of Florida, Gainesville, FL. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Novo Nordisk Diabetes Research & Development Center, Seattle, WA. · Pubmed 28830918
2016
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. · Department of Clinical Immunology, University Hospital, Uppsala, Sweden. · Departments of Pathology and Pediatrics, University of Florida, Gainesville, FL, USA. · Pubmed 25989477
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA; Novo Nordisk Diabetes Research & Development Center, Seattle, WA, USA. Electronic address: · Pubmed 27491567
  • Institute of Immunity and Transplantation, University College London Division of Infection and Immunity, Royal Free Campus, London, UK. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA and Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. · Pubmed 26102289
  • Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA. Electronic address: · Pubmed 26821303
2015
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA; Pacific Northwest Diabetes Research Institute, Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. Electronic address: · Pubmed 26122172
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California (TRC, JSS, NA, JZG, FA, SS, MGVH) · Department of Immunohematology & Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands (JSS) · Novo Nordisk Diabetes Research & Development Center, Seattle, Washington (MGVH) · Pubmed 26216138
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Novo Nordisk Diabetes Research and Development Center, Seattle, WA · Pubmed 25908875
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk, Inc., Seattle, WA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Type 1 Diabetes R&D Center, Novo Nordisk, Inc., Seattle, WA, USA. Electronic address: · Pubmed 25772283
2014
  • Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA. · Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA. · Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA; Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA. · Pubmed 25393309
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, La Jolla, CA · Pubmed 25342729
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Department of Rheumatology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · Freelance consultant, San Diego, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Novo Nordisk Diabetes Research & Development Center, Seattle, WA · Pubmed 24947367
  • La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; University of California San Diego, San Diego, CA, USA. · University of California San Diego, San Diego, CA, USA. · Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA. · Ayasdi, Inc., Palo Alto, CA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA. Electronic address: · Pubmed 24387802
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; University of California San Diego, San Diego, CA, USA. · University of California San Diego, San Diego, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. Electronic address: · Pubmed 25173803
2014
  • Type 1 Diabetes R&D Center; Novo Nordisk Inc.; Seattle, WA USA; Pacific Northwest Diabetes Research Institute; Seattle, WA USA. · Pubmed 24165565
2013
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. · Pubmed 23490422
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 53 total) written by Matthias G. von Herrath about Diabetes Mellitus:

  • The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies? 2018
  • Immunotherapy for Type 1 Diabetes: Why Do Current Protocols Not Halt the Underlying Disease Process? 2017
  • Antigen-Specific Peptide Immunotherapy for Type 1 Diabetes: Proof of Safety, Hope for Efficacy. 2017
  • Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes. 2017
  • Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice. 2017
  • Alpha cells, the main source of IL-1β in human pancreas. 2017
  • Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. 2017
  • Immunohistochemical assessment of glucagon-like peptide 1 receptor (GLP-1R) expression in the pancreas of patients with type 2 diabetes. 2017
  • Response to Comment on Rodriguez-Calvo et al. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017;66:1334-1345. 2017
  • Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary? 2017
Show List of Full Article Records
Google Searches

Learn more about Matthias G. von Herrath using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
La Jolla Institute for Allergy and Immunology
Novo Nordisk Seattle
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
La Jolla Institute for Allergy and Immunology
2018
  • Department of Medicine, University of California, San Diego, San Diego, CA, USA. · Clinical and Translational Research Institute, University of California, San Diego, 9452 Medical Center Drive, L1W-515, La Jolla, CA, 920137, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, USA. · Novo Nordisk Diabetes Research and Development Center, 530 Fairview Ave N # 5000, Seattle, WA, USA. · Pubmed 29188386
2017
  • West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, Hohensandweg 37, 40591 Düsseldorf, Germany; Faculty of Medicine, University of Düsseldorf, 40225 Düsseldorf, Germany. Electronic address: · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92014, USA; Novo Nordisk Diabetes Research and Development Center, Seattle, WA 98191, USA. Electronic address: · Pubmed 27839907
  • Global Research Project Management, Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes Research Center, Novo Nordisk, Seattle, WA, USA; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92014, USA. Electronic address: · Pubmed 28978425
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Diabetes Research & Development Center, Seattle, Washington, USA. Electronic address: · Pubmed 28325643
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Division of Paediatric and Adolescent Medicine, Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Novo Nordisk Diabetes Research & Development Center, Seattle, WA. · Pubmed 28137793
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Institute of Diabetes Research, Helmholtz Diabetes Center, Helmholtz Zentrum München, Neuherberg, Germany. · Department of Pathology, University of Florida, Gainesville, FL. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Novo Nordisk Diabetes Research & Development Center, Seattle, WA. · Pubmed 28830918
  • Department of Pathology, Immunology, and Laboratory Medicine, 1395 Center Drive, College of Medicine, University of Florida, Gainesville, 32610, FL, USA. · Department of Pathology, Immunology, and Laboratory Medicine, 1395 Center Drive, College of Medicine, University of Florida, Gainesville, 32610, FL, USA. · Larry L. Hillblom Islet Research Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Cell Biology, University of Groningen, Groningen, the Netherlands. · Department of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Department of Virology, University of Tampere and Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland. · St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia. · University of Exeter Medical School, Exeter, UK. · Vanderbilt University Medical Center, Nashville, TN, USA. · Miller School of Medicine, University of Miami, Miami, FL, USA. · Department of Pathology, Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium. · Pubmed 28070616
2016
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. · Department of Clinical Immunology, University Hospital, Uppsala, Sweden. · Departments of Pathology and Pediatrics, University of Florida, Gainesville, FL, USA. · Pubmed 25989477
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA; Novo Nordisk Diabetes Research & Development Center, Seattle, WA, USA. Electronic address: · Pubmed 27491567
  • Institute of Immunity and Transplantation, University College London Division of Infection and Immunity, Royal Free Campus, London, UK. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA and Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. · Pubmed 26102289
  • Islet Biology Exeter (IBEx), Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, RILD Building (Level 4), Barrack Road, Exeter, EX2 5DW, UK. · La Jolla Institute for Allergy and Immunology, San Diego, CA, USA. · Department of Medicine, University of Tennessee, Memphis, TN, USA. · Department of Pathology, University of Florida, Gainesville, FL, USA. · Department of Information Sciences, City of Hope, Duarte, CA, USA. · Islet Biology Exeter (IBEx), Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, RILD Building (Level 4), Barrack Road, Exeter, EX2 5DW, UK. · Paediatric Department, Oslo University Hospital, Oslo, Norway. · Faculty of Medicine, University of Oslo, Oslo, Norway. · Diabetes Research Institute, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Miami Miller School of Medicine, Miami, FL, USA. · Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA. · Islet Biology Exeter (IBEx), Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, RILD Building (Level 4), Barrack Road, Exeter, EX2 5DW, UK. · Pubmed 27506584
  • Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA. Electronic address: · Pubmed 26821303
  • Departments of Surgery and Immunology, University of Colorado Denver, Aurora, CO · La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Departments of Surgery and Immunology, University of Colorado Denver, Aurora, CO. · Department of Pathology, University of Florida, Gainesville, FL. · Yale University School of Medicine, New Haven, CT. · Immune Tolerance Network, University of California, San Francisco, San Francisco, CA. · Immune Tolerance Network, Bethesda, MD. · JDRF, New York, NY. · Benaroya Research Institute, Seattle, WA. · Pubmed 26718498
2015
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California (TRC, JSS, NA, JZG, FA, SS, MGVH) · Department of Immunohematology & Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands (JSS) · Novo Nordisk Diabetes Research & Development Center, Seattle, Washington (MGVH) · Pubmed 26216138
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Novo Nordisk Diabetes Research and Development Center, Seattle, WA · Pubmed 25908875
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk, Inc., Seattle, WA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Type 1 Diabetes R&D Center, Novo Nordisk, Inc., Seattle, WA, USA. Electronic address: · Pubmed 25772283
  • Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, CA · Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, CA. · Department of Medicine, Columbia Center for Translational Immunology and Naomi Berrie Diabetes Center, Columbia University Medical Center, New York, NY. · Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Pubmed 25187368
2014
  • Department of Pediatrics, Herlev University Hospital, 2730 Herlev, Denmark;Glostrup Research Institute, Glostrup University Hospital, 2600 Glostrup, Denmark. · Department of Pediatrics, Herlev University Hospital, 2730 Herlev, Denmark; · Laboratory of Experimental Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium; · Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet, 2100 Copenhagen, Denmark; · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; · Global Development, Novo Nordisk A/S, 2860 Søborg, Denmark; · Department of Internal Medicine, University of Ulm, 89081 Ulm, Germany; · Department of Internal Medicine, University of Ulm, 89081 Ulm, Germany;Lee Kong Chian School of Medicine, Imperial College London and Nanyang Technological University, Singapore 637553; · Centre for Diabetes Research, Western Australian Institute for Medical Research, University of Western Australia, Perth, WA 6000, Australia; · Genetics Institute, University of Florida, Gainesville, FL 32610; · Hagedorn Research Institute, Novo Nordisk, 2820 Gentofte, Denmark; · Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; and. · Institute of Molecular Medicine and Cell Research and Centre for Biological Signalling Studies, Albert Ludwigs University, 79085 Freiburg, Germany. · Department of Pediatrics, Herlev University Hospital, 2730 Herlev, Denmark;Glostrup Research Institute, Glostrup University Hospital, 2600 Glostrup, Denmark,Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; and · Pubmed 24982147
  • Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA. · Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA. · Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA; Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA. · Pubmed 25393309
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, La Jolla, CA · Pubmed 25342729
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Department of Rheumatology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · Freelance consultant, San Diego, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Novo Nordisk Diabetes Research & Development Center, Seattle, WA · Pubmed 24947367
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Pubmed 24858581
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. Electronic address: · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · The School of Molecular Bioscience, University of Sydney, NSW 2006, Australia. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. Electronic address: · Pubmed 24582317
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Pubmed 24520125
  • La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; University of California San Diego, San Diego, CA, USA. · University of California San Diego, San Diego, CA, USA. · Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA. · Ayasdi, Inc., Palo Alto, CA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA. Electronic address: · Pubmed 24387802
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; University of California San Diego, San Diego, CA, USA. · University of California San Diego, San Diego, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. Electronic address: · Pubmed 25173803
2013
  • Center for Type 1 Diabetes Research, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Pubmed 23574316
  • Department for Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands. · Bayhill Therapeutics, Palo Alto, CA 94304, USA. · Foothill College, Los Altos, CA 94022, USA. · Barbara Davis Center for Childhood Diabetes, Aurora, CO 80045-6511, USA. · Division of Molecular Medicine, Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria 3052, Australia. · Pacific Northwest Diabetes Research Institute and University of Washington, Seattle, WA 98122, USA. · Diabetes Center for Research, University of North Carolina, Chapel Hill, NC 27599, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. · Departments of Medicine and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA. · Tolerion Inc., 321 Dedalera Drive, Portola Valley, CA 94028, USA. · Pubmed 23803704
2016
  • Type 1 Diabetes Center at the La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Pubmed 26300527
2014
  • La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA. · Pubmed 25073445
2013
  • Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Pubmed 23194064
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America. · Pubmed 24223938
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Pubmed 23770292
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA. · Pubmed 23434930
  • La Jolla Institute for Allergy and Immunology, Diabetes Center, La Jolla, CA, USA. · Pubmed 23405091
  • Type 1 Diabetes Center of San Diego, La Jolla Institute for Allergy and Immunology, La Jolla, 9420 Athena Circle, San Diego, CA 92037, USA. · Pubmed 22944096
  • La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Pubmed 24211845
2012
  • Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. · Pubmed 23051179
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. · Pubmed 22579473
Novo Nordisk Seattle
2018
  • Department of Medicine, University of California, San Diego, San Diego, CA, USA. · Clinical and Translational Research Institute, University of California, San Diego, 9452 Medical Center Drive, L1W-515, La Jolla, CA, 920137, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, USA. · Novo Nordisk Diabetes Research and Development Center, 530 Fairview Ave N # 5000, Seattle, WA, USA. · Pubmed 29188386
2017
  • West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, Hohensandweg 37, 40591 Düsseldorf, Germany; Faculty of Medicine, University of Düsseldorf, 40225 Düsseldorf, Germany. Electronic address: · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92014, USA; Novo Nordisk Diabetes Research and Development Center, Seattle, WA 98191, USA. Electronic address: · Pubmed 27839907
  • Global Research Project Management, Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes Research Center, Novo Nordisk, Seattle, WA, USA; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92014, USA. Electronic address: · Pubmed 28978425
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA; Pacific Northwest Diabetes Research Institute, Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Department of Histology and Imaging, Novo Nordisk A/S, Måløv, Denmark. · Department of Immunopharmacology, Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. Electronic address: · Pubmed 28711285
  • Molecular Development of the Immune System Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID) and Clinical Genomics Program, NIAID, National Institutes of Health, Building 10, Room 11D14, 10 Center Drive, Bethesda, MD, 20814, USA. · Novo Nordisk Type 1 Diabetes Center, Novo Nordisk Research Center, Seattle, WA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Wellstat Diagnostics, Gaithersburg, MD, USA. · Molecular Development of the Immune System Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID) and Clinical Genomics Program, NIAID, National Institutes of Health, Building 10, Room 11D14, 10 Center Drive, Bethesda, MD, 20814, USA. · Pubmed 28455654
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Diabetes Research & Development Center, Seattle, Washington, USA. Electronic address: · Pubmed 28325643
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Division of Paediatric and Adolescent Medicine, Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Novo Nordisk Diabetes Research & Development Center, Seattle, WA. · Pubmed 28137793
  • Histology and Imaging Department, Global Research, Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes Research Center, Global Research, Novo Nordisk Inc., Seattle, Washington. · Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Visiopharm, Hørsholm, Denmark. · Metabolic Disease Research, Global Research, Novo Nordisk A/S, Måløv, Denmark. · Pubmed 28094469
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Institute of Diabetes Research, Helmholtz Diabetes Center, Helmholtz Zentrum München, Neuherberg, Germany. · Department of Pathology, University of Florida, Gainesville, FL. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA · Novo Nordisk Diabetes Research & Development Center, Seattle, WA. · Pubmed 28830918
2016
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. · Department of Clinical Immunology, University Hospital, Uppsala, Sweden. · Departments of Pathology and Pediatrics, University of Florida, Gainesville, FL, USA. · Pubmed 25989477
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA; Novo Nordisk Diabetes Research & Development Center, Seattle, WA, USA. Electronic address: · Pubmed 27491567
  • Institute of Immunity and Transplantation, University College London Division of Infection and Immunity, Royal Free Campus, London, UK. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA and Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. · Pubmed 26102289
  • Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Novo Nordisk A/S, Måløv, Denmark. · Type 1 Diabetes R&D Center, Novo Nordisk Research Center, Seattle, WA, USA. Electronic address: · Pubmed 26821303
2015
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA; Pacific Northwest Diabetes Research Institute, Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. Electronic address: · Pubmed 26122172
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California (TRC, JSS, NA, JZG, FA, SS, MGVH) · Department of Immunohematology & Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands (JSS) · Novo Nordisk Diabetes Research & Development Center, Seattle, Washington (MGVH) · Pubmed 26216138
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Novo Nordisk Diabetes Research and Development Center, Seattle, WA · Pubmed 25908875
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes R&D Center, Novo Nordisk, Inc., Seattle, WA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Type 1 Diabetes R&D Center, Novo Nordisk, Inc., Seattle, WA, USA. Electronic address: · Pubmed 25772283
2014
  • Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA. · Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA. · Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA; Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA. · Pubmed 25393309
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA. · Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, La Jolla, CA · Pubmed 25342729
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Department of Rheumatology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · Freelance consultant, San Diego, CA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA Novo Nordisk Diabetes Research & Development Center, Seattle, WA · Pubmed 24947367
  • La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; University of California San Diego, San Diego, CA, USA. · University of California San Diego, San Diego, CA, USA. · Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA. · Ayasdi, Inc., Palo Alto, CA, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Type 1 Diabetes R & D Center, Seattle, WA, USA. Electronic address: · Pubmed 24387802
  • Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; University of California San Diego, San Diego, CA, USA. · University of California San Diego, San Diego, CA, USA. · Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA; Novo Nordisk Diabetes Research and Development Center, Seattle, WA, USA. Electronic address: · Pubmed 25173803
2014
  • Type 1 Diabetes R&D Center; Novo Nordisk Inc.; Seattle, WA USA; Pacific Northwest Diabetes Research Institute; Seattle, WA USA. · Pubmed 24165565
2013
  • Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. · Pubmed 23490422
7 Other Locations Show
Yearly article counts 1976111450000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.